Director/PDMR Shareholding
09 December 2010 - 2:52AM
UK Regulatory
TIDMGWP
RNS Number : 6199X
GW Pharmaceuticals PLC
08 December 2010
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 8 December 2010: GW Pharmaceuticals (AIM: GWP) hereby provides
notification that the Company has today been notified of the following share
transactions entered into today by Mr Thomas Lynch, a non-executive Director and
Dr Geoffrey Guy, a Director and Executive Chairman of the Company.
Mr Thomas Lynch purchased 47,665 ordinary shares of 0.1p each from Dr Geoffrey
Guy. This transaction between Directors, which equates to 0.04% of the issued
ordinary share capital of the company, took place at the prevailing market price
of 104.9 pence per share.
Dr Guy has also today transferred 4,256 ordinary shares of 0.1p each, equating
to less than 0.01% of the issued ordinary share capital of the company, into his
personal pension scheme. This transaction took place at the prevailing market
price of 106.75 pence per share.
Following this notification:
Mr Lynch's holding in the shares of GW Pharmaceuticals PLC is 47,665 ordinary
shares, amounting to 0.04% of shares in issue.
Dr Guy retains a beneficial interest in 18,306,783 ordinary shares, amounting to
13.95% of the shares in issue.
The total number of shares outstanding in the Company is 131,243,292 ordinary
shares of 0.1p each.
For further information, please contact:
GW Pharmaceuticals PLC +44
(0)1980 557 000
Adam George, Company Secretary
Peel Hunt Ltd (Nominated Adviser)
James Steel/Vijay Barathan +44
(0) 207 418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFEEFLLTIII
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles